Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations
Open accessThe DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To describe the use and reporting of interrupted time series methods in drug utilization research. STUDY DESIGN AND SETTING: We completed a systematic search of MEDLINE, Web of Science, and reference lists to identify English language articles through to December 2013 that used interrupted time series methods in drug utilization research. We tabulated the number of studies by publication year and summarized methodological detail. RESULTS: We identified 220 eligible empirical applications since 1984. Only 17 (8%) were published before 2000, and 90 (41%) were published since 2010. Segmented regression was the most commonly applied interrupted time series method (67%). Most studies assessed drug policy changes (51%, n = 112); 22% (n = 48) examined the impact of new evidence, 18% (n = 39) examined safety advisories, and 16% (n = 35) examined quality improvement interventions. Autocorrelation was considered in 66% of studies, 31% reported adjusting for seasonality, and 15% accounted for nonstationarity. CONCLUSION: Use of interrupted time series methods in drug utilization research has increased, particularly in recent years. Despite methodological recommendations, there is large variation in reporting of analytic methods. Developing methodological and reporting standards for interrupted time series analysis is important to improve its application in drug utilization research, and we provide recommendations for consideration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distribution of the Estimators for Autoregressive Time Series with a Unit Root
Dickey, D. A., & Fuller, W. A. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10482531 · Cited by 23,211
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Time Series Analysis: Forecasting and Control
Geurts, M., Box, G. E. P., & Jenkins, G. M. (1977) · Journal of Marketing Research · doi:10.2307/3150485 · Cited by 19,186
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Distribution of the Estimators for Autoregressive Time Series With a Unit Root
Dickey, D. A., & Fuller, W. A. (1979) · Journal of the American Statistical Association · doi:10.2307/2286348 · Cited by 9,106
On a measure of lack of fit in time series models
LJUNG, G. M., & BOX, G. E. P. (1978) · Biometrika · doi:10.1093/biomet/65.2.297 · Cited by 6,668
Time Series Analysis: Forecasting and Control
Kleiner, B. (1977) · Technometrics · doi:10.1080/00401706.1977.10489562 · Cited by 6,446
TESTING FOR SERIAL CORRELATION IN LEAST SQUARES REGRESSION. II
DURBIN, J., & WATSON, G. S. (1951) · Biometrika · doi:10.1093/biomet/38.1-2.159 · Cited by 3,619
Segmented regression analysis of interrupted time series studies in medication use research
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00430.x · Cited by 3,279 · cited 10×
“Depending on the minimum effect size and the amount of variation, a minimum of nine data points preintervention, postintervention, and when applicable, between interventions [4,12], and at least 100 observations per data point is encouraged [3].”
BackgroundMethodInfluentialRates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
Self-citationUse of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements
Penfold, R. B., & Zhang, F. (2013) · Academic Pediatrics · doi:10.1016/j.acap.2013.08.002 · Cited by 1,150
The Use and Interpretation of Quasi-Experimental Studies in Medical Informatics
Harris, A. D., McGregor, J. C., Perencevich, E. N., Furuno, J. P., Zhu, J., Peterson, D. E., & Finkelstein, J. (2006) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m1749 · Cited by 1,023
Testing for Serial Correlation in Least Squares Regression: I
Durbin, J., & Watson, G. S. (1950) · Biometrika · doi:10.2307/2332391 · Cited by 955
Soumerai, S. B., McLaughlin, T. J., Ross-Degnan, D., Casteris, C. S., & Bollini, P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311006 · Cited by 480
Sheldon, T. A., Cullum, N., Dawson, D., Lankshear, A., Lowson, K., Watt, I., West, P., Wright, D., & Wright, J. (2004) · BMJ · doi:10.1136/bmj.329.7473.999 · Cited by 433
Payment Restrictions for Prescription Drugs under Medicaid
Soumerai, S. B., Avorn, J., Ross-Degnan, D., & Gortmaker, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708273170906 · Cited by 409
Experimental and quasi-experimental designs for evaluating guideline implementation strategies
Grimshaw, J. (2000) · Family Practice · doi:10.1093/fampra/17.suppl_1.s11 · Cited by 382
Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results
Haas, J. S., Kaplan, C. P., Gerstenberger, E. P., & Kerlikowske, K. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00009 · Cited by 314
Zhang, F., Wagner, A. K., & Ross-Degnan, D. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.02.007 · Cited by 291
How to do (or not to do) … Assessing the impact of a policy change with routine longitudinal data
Lagarde, M. (2012) · Health Policy and Planning · doi:10.1093/heapol/czr004 · Cited by 290
Serumaga, B., Ross-Degnan, D., Avery, A. J., Elliott, R. A., Majumdar, S. R., Zhang, F., & Soumerai, S. B. (2011) · BMJ · doi:10.1136/bmj.d108 · Cited by 284
Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs
Libby, A. M., Brent, D. A., Morrato, E. H., Orton, H. D., Allen, R., & Valuck, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.884 · Cited by 281
Zhang, F., Wagner, A. K., Soumerai, S. B., & Ross-Degnan, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.08.007 · Cited by 247
Durieux, P., Nizard, R., Ravaud, P., Mounier, N., & Lepage, E. (2000) · JAMA · doi:10.1001/jama.283.21.2816 · Cited by 240
Impact of FDA Black Box Advisory on Antipsychotic Medication Use
Dorsey, E. R. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.456 · Cited by 240
Ansari, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg459 · Cited by 222
Linden, A., & Adams, J. L. (2011) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01504.x · Cited by 219
Gillings, D., Makuc, D., & Siegel, E. (1981) · American Journal of Public Health · doi:10.2105/ajph.71.1.38 · Cited by 216
Changes in Antipsychotic Drug Use in Nursing Homes During Implementation of the OBRA-87 Regulations
Shorr, R. I. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510290040034 · Cited by 202
Talpaert, M. J., Gopal Rao, G., Cooper, B. S., & Wade, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr253 · Cited by 200
Elligsen, M., Walker, S. A. N., Pinto, R., Simor, A., Mubareka, S., Rachlis, A., Allen, V., & Daneman, N. (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/664757 · Cited by 196
Fowler, S., Webber, A., Cooper, B. S., Phimister, A., Price, K., Carter, Y., Kibbler, C. C., Simpson, A. J. H., & Stone, S. P. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm014 · Cited by 190
Katz, L. Y., Kozyrskyj, A. L., Prior, H. J., Enns, M. W., Cox, B. J., & Sareen, J. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071265 · Cited by 173
Promotion and Prescribing of Hormone Therapy After Report of Harm by the Women’s Health Initiative
Majumdar, S. R. (2004) · JAMA · doi:10.1001/jama.292.16.1983 · Cited by 172
Persisting Decline in Depression Treatment After FDA Warnings
Libby, A. M., Orton, H. D., & Valuck, R. J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.46 · Cited by 169
Aldeyab, M. A., Kearney, M. P., Scott, M. G., Aldiab, M. A., Alahmadi, Y. M., Darwish Elhajji, F. W., Magee, F. A., & McElnay, J. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks330 · Cited by 165
National trends in antidepressant medication treatment among publicly insured pregnant women
Huybrechts, K. F., Palmsten, K., Mogun, H., Kowal, M., Avorn, J., Setoguchi-Iwata, S., & Hernández-Díaz, S. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.12.010 · Cited by 161
Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample
Olfson, M., Marcus, S. C., & Druss, B. G. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.5 · Cited by 161
Buising, K. L., Thursky, K., Robertson, M. B., Black, J., Street, A., Richards, M. J., & Brown, G. V. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn218 · Cited by 151
Schneeweiß, S., Patrick, A. R., Maclure, M., Dormuth, C. R., & Glynn, R. J. (2007) · Circulation · doi:10.1161/circulationaha.106.665992 · Cited by 145
Valuck, R. J., Libby, A. M., Orton, H. D., Morrato, E. H., Allen, R. R., & Baldessarini, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010007 · Cited by 137
Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico
Santa-Ana-Tellez, Y., Mantel-Teeuwisse, A. K., Dreser, A., Leufkens, H. G. M., & Wirtz, V. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075550 · Cited by 135
van Kasteren, M. E. E., Manniën, J., Kullberg, B. J., de Boer, A. S., Nagelkerke, N. J. D., Ridderhof, M., Wille, J. C., & Gyssens, I. C. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki374 · Cited by 135
Jump, R., Olds, D. M., Seifi, N., Kypriotakis, G., Jury, L. A., Peron, E. P., Hirsch, A., Drawz, P. E., Watts, B., Bonomo, R. A., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668429 · Cited by 134
Valiyeva, E., Herrmann, N., Rochon, P. A., Gill, S. S., & Anderson, G. M. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071540 · Cited by 129
McCoy, A. B., Waitman, L. R., Gadd, C. S., Danciu, I., Smith, J. P., Lewis, J. B., Schildcrout, J. S., & Peterson, J. F. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.05.024 · Cited by 124
Sun, S. X., Lee, K. Y., Bertram, C. T., & Goldstein, J. L. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x210561 · Cited by 118
Smith, D. H., Perrin, N., Feldstein, A., Yang, X., Kuang, D., Simon, S. R., Sittig, D. F., Platt, R., & Soumerai, S. B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1098 · Cited by 114
The Effect of a Medicaid Drug Copayment Program on the Utilization and Cost of Prescription Services
Nelson, A. A., Reeder, C. E., & Dickson, W. M. (1984) · Medical Care · doi:10.1097/00005650-198408000-00004 · Cited by 113
Fretheim, A., Soumerai, S. B., Zhang, F., Oxman, A. D., & Ross‐Degnan, D. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.03.016 · Cited by 112
Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors
Fischer, M. A., Schneeweiß, S., Avorn, J., & Solomon, D. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmsa042770 · Cited by 111
The impact of co‐payment increases on dispensings of government‐subsidised medicines in Australia
Hynd, A., Roughead, E. E., Preen, D. B., Glover, J. D., Bulsara, M. K., & Semmens, J. B. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1670 · Cited by 106
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.
Schneeweiß, S., Soumerai, S. B., Glynn, R. J., Maclure, M., Dormuth, C. R., & Walker, A. M. (2002) · PubMed Central · Cited by 102
Roblin, D. W., Platt, R. G., Goodman, M. J., Hsu, J., Nelson, W. W., Smith, D. H., Andrade, S. E., & Soumerai, S. B. (2005) · Medical Care · doi:10.1097/01.mlr.0000178216.23514.b7 · Cited by 98
Persell, S. D., Kaiser, D., Dolan, N. C., Andrews, B., Levi, S., Khandekar, J. D., Gavagan, T. F., Thompson, J. A., Friesema, E. M., & Baker, D. W. (2010) · Medical Care · doi:10.1097/mlr.0b013e318202913d · Cited by 94
A critical review of methods to evaluate the impact of FDA regulatory actions
Briesacher, B. A., Soumerai, S. B., Zhang, F., Toh, S., Andrade, S. E., Wagner, J. L., Shoaibi, A., & Gurwitz, J. H. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3480 · Cited by 91
Magedanz, L., Siliprandi, E. M. O., & dos Santos, R. P. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9621-7 · Cited by 91
Soumerai, S. B., Avorn, J., Gortmaker, S. L., & Hawley, S. L. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.12.1518 · Cited by 88
Buising, K. L., Thursky, K., Black, J., MacGregor, L., Street, A., Kennedy, M. P., & Brown, G. V. (2008) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-8-35 · Cited by 86
Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis
Mol, P. G. M., Wieringa, J. E., NannanPanday, P. V., Gans, R. O. B., Degener, J. E., Laseur, M., & Haaijer‐Ruskamp, F. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki037 · Cited by 83
Pharmaceutical policies: effects of restrictions on reimbursement
Green, C. J., Maclure, M., Fortin, P. M., Ramsay, C. R., Aaserud, M., & Bardal, S. K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008654 · Cited by 82
Cardiovascular Outcomes after a Change in Prescription Policy for Clopidogrel
Jackevicius, C. A., Tu, J. V., Demers, V., de Melo, M. N., Cox, J. L., Rinfret, S., Kalavrouziotis, D., Johansen, H., Behlouli, H., Newman, A. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0803410 · Cited by 81
Examining product risk in context. Market withdrawal of zomepirac as a case study.
Ross‐Degnan, D., Soumerai, S. B., Fortess, E. E., & Gurwitz, J. H. (1993) · PubMed · Cited by 80
Aiken, A. M., Wanyoro, A. K., Mwangi, J., Juma, F., Mugoya, I., & Scott, J. A. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078942 · Cited by 80
Majumdar, S. R., McAlister, F. A., & Soumerai, S. B. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00422-4 · Cited by 80
Yeo, C. L., Chan, D. S.-G., Earnest, A., Wu, T. S., Yeoh, S. F., Lim, R., Jureen, R., Fisher, D. A., & Hsu, L. Y. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1351-6 · Cited by 79
Delate, T., MAGER, D. E., Sheth, J., & Motheral, B. R. (2005) · PubMed · Cited by 79
The analysis of change: Issues, fallacies, and new ideas.
Gottman, J. M., & Rushe, R. H. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.61.6.907 · Cited by 78
Lu, C. Y., Soumerai, S. B., Ross‐Degnan, D., Zhang, F., & Adams, A. S. (2009) · Medical Care · doi:10.1097/mlr.0b013e3181bd4c10 · Cited by 77
Effect of New York State Regulatory Action on Benzodiazepine Prescribing and Hip Fracture Rates
Wagner, A. K., Ross-Degnan, D., Gurwitz, J. H., Zhang, F., Gilden, D. B., Cosler, L., & Soumerai, S. B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00004 · Cited by 73
MARTIN, B. C., & MCMILLAN, J. A. (1996) · Medical Care · doi:10.1097/00005650-199607000-00003 · Cited by 73
Dormuth, C. R., Glynn, R. J., Neumann, P. J., Maclure, M., Brookhart, A. M., & Schneeweiß, S. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.06.007 · Cited by 73
Use of the Statins in Patients After Acute Myocardial Infarction: Does Evidence Change Practice?
Jackevicius, C. A., Anderson, G., Leiter, L. A., & Tu, J. V. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.183 · Cited by 72
Choudhry, N. K., Fischer, M. A., Avorn, J., Lee, J. L.-Y., Schneeweiß, S., Solomon, D. H., Berman, C., Jan, S., Lii, J., Mahoney, J. J., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.050 · Cited by 70
Gibson, T. B., Wang, S., Kelly, E. D., Brown, C., Turner, C., Frech‐Tamas, F., Doyle, J., & Mauceri, E. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.0510 · Cited by 69
Austin, P. C., & Mamdani, M. (2005) · Circulation · doi:10.1161/circulationaha.104.531582 · Cited by 68
Self-citationClinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers
Schneeweiß, S., Soumerai, S. B., Maclure, M., Dormuth, C., Walker, A. M., & Glynn, R. J. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00227-3 · Cited by 68
Effectiveness of Antimicrobial Guidelines for Community-Acquired Pneumonia in Children
Smith, M. J., Kong, M., Cambon, A. C., & Woods, C. R. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2412 · Cited by 67
Case‐crossover study design in pharmacoepidemiology: systematic review and recommendations
Consiglio, G. P., Burden, A. M., Maclure, M., McCarthy, L. M., & Cadarette, S. M. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3508 · Cited by 67
Self-citationRoss‐Degnan, D., Simoni, J. M., Brown, J. S., Gao, X., Mah, C., Cosler, L. E., Fanning, T. R., Gallagher, P., Salzman, C., Shader, R. I., et al. (2004) · The International Journal of Psychiatry in Medicine · doi:10.2190/8fr4-qyy1-7myg-2agj · Cited by 66
Everitt, D. E., Soumerai, S. B., Avorn, J., Klapholz, H., & Wessels, M. (1990) · Infection Control and Hospital Epidemiology · doi:10.1086/646098 · Cited by 66
The Impact of the Canadian Hypertension Education Program on Antihypertensive Prescribing Trends
Campbell, N. R. C., Tu, K., Brant, R., Duong-Hua, M., & McAlister, F. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000196269.98463.fd · Cited by 66
Valluri, S., ZITO, J. M., Safer, D. J., Zuckerman, I. H., Mullins, C. D., & Korelitz, J. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181ef9d2b · Cited by 65
Disease risk score as a confounder summary method: systematic review and recommendations
Tadrous, M., Gagne, J. J., Stürmer, T., & Cadarette, S. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3377 · Cited by 65
Self-citationPrescribing trends before and after implementation of an antimicrobial stewardship program
Cairns, K. A., Jenney, A. W. J., Abbott, I. J., Skinner, M. J., Doyle, J., Dooley, M. J., & Cheng, A. C. (2013) · The Medical Journal of Australia · doi:10.5694/mja12.11683 · Cited by 63
Zhang, Y., Adams, A. S., Ross‐Degnan, D., Zhang, F., & Soumerai, S. B. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.4.520 · Cited by 63
Cook, P., Rizzo, S., Gooch, M. D., Jordan, M., Fang, X., & Hudson, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq404 · Cited by 62
Price, J. R., Cheek, E., Lippett, S., Cubbon, M., Gerding, D. N., Sambol, S. P., Citron, D. M., & Llewelyn, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03077.x · Cited by 61
Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?
Andersson, K., Petzold, M. G., Sonesson, C., Lönnroth, K., & Carlsten, A. (2006) · Health Policy · doi:10.1016/j.healthpol.2006.01.007 · Cited by 60
Hartung, D. M., Carlson, M. J., Kraemer, D. F., Haxby, D. G., Ketchum, K. L., & Greenlick, M. R. (2008) · Medical Care · doi:10.1097/mlr.0b013e3181734a77 · Cited by 60
Campbell, N. R. C., McAlister, F. A., Brant, R., Levine, M., Drouin, D., Feldman, R. D., Herman, R. J., & Zarnke, K. B. (2003) · Journal of Hypertension · doi:10.1097/00004872-200308000-00025 · Cited by 60
Do medical cannabis laws encourage cannabis use?
Gorman, D. M., & Huber, J. C. (2006) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.10.001 · Cited by 59
Effect of the Women's Health Initiative on Osteoporosis Therapy and Expenditure in Medicaid
Udell, J. A., Fischer, M. A., Brookhart, M. A., Solomon, D. H., & Choudhry, N. K. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060119 · Cited by 57
Prescription Drug Utilization Following Patient Co-Payment Changes in Australia
McManus, P. R., DONNELLY, N., HENRY, D., Hall, W., Primrose, J. G., & Lindner, J. (1996) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199611)5:6<385::aid-pds246>3.0.co;2-8 · Cited by 56
Nyasulu, J. C. Y., Muchiri, E., Mazwi, S. L., & Ratshefola, M. (2012) · South African Medical Journal · doi:10.7196/samj.6380 · Cited by 56
Blais, L., Couture, J., Rahme, E., & LeLorier, J. (2003) · Health Policy · doi:10.1016/s0168-8510(02)00158-6 · Cited by 55
Garg, R. K., Fulton‐Kehoe, D., Turner, J. A., Bauer, A. M., Wickizer, T. M., Sullivan, M. D., & Franklin, G. M. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.08.001 · Cited by 54
Tu, K., Mamdani, M., Jacka, R. M., Forde, N. J., Rothwell, D. M., & Tu, J. V. (2003) · Europe PMC (PubMed Central) · Cited by 53
Self-citationPető, Z., Benkő, R., Matúz, M., Csüllög, E., Molnar, A., & Hajdú, E. (2008) · Infection · doi:10.1007/s15010-008-7377-8 · Cited by 52
A therapeutic substitution policy for proton pump inhibitors: Clinical and economic consequences
Schneeweiß, S., Maclure, M., Dormuth, C. R., Glynn, R. J., Canning, C. F., & Avorn, J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.12.304 · Cited by 52
Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009
Cohen, A. J., Rabbani, A., Shah, N. D., & Alexander, G. C. (2010) · Diabetes Care · doi:10.2337/dc09-1834 · Cited by 51
Simoni, J. M., Ross‐Degnan, D., Mah, C., Gao, X., Brown, J. S., Cosler, L. E., Fanning, T. R., Gallagher, P., Salzman, C., & Soumerai, S. B. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90030-6 · Cited by 51
The Effect of Antidepressant Warnings on Prescribing Trends in Ontario, Canada
Kurdyak, P. A., Juurlink, D. N., & Mamdani, M. (2007) · American Journal of Public Health · doi:10.2105/ajph.2006.087262 · Cited by 50
Self-citationEffects of state surveillance on new post-hospitalization benzodiazepine use
Wagner, A. K., Soumerai, S. B., Zhang, F., Mah, C., Simoni‐Wastila, L., Cosler, L., Fanning, T., Gallagher, P., & Ross-Degnan, D. (2003) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzg064 · Cited by 50
Impact of a Multipronged Education Strategy on Antibiotic Prescribing in Quebec, Canada
Weiss, K., Blais, R., Fortin, A., Lantin, S., & Gaudet, M. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir409 · Cited by 50
Naughton, C., Feely, J., & Bennett, K. (2009) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01099.x · Cited by 49
Guthrie, B., Clark, S. A., Reynish, E. L., McCowan, C., & Morales, D. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068976 · Cited by 49
Hagen, B. F., Armstrong-Esther, C., Quail, P., Williams, R. J., Norton, P., Navenec, C.-L. L., Ikuta, R. M., Osis, M., Congdon, V., & Zieb, R. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205002188 · Cited by 47
Briesacher, B. A., Zhao, Y., Madden, J. M., Zhang, F., Adams, A. S., Tjia, J., Ross‐Degnan, D., Gurwitz, J. H., & Soumerai, S. B. (2011) · Medical Care · doi:10.1097/mlr.0b013e3182162afb · Cited by 45
Ruiter, R., Visser, L. E., van Herk‐Sukel, M. P. P., Geelhoed-Duijvestijn, P. H. L. M., de Bie, S., Straus, S. M. J. M., Mol, P. G. M., Romio, S., Herings, R. M. C., & Stricker, B. H. C. (2012) · Drug Safety · doi:10.2165/11596950-000000000-00000 · Cited by 44
Slekovec, C., Leroy, J., Vernaz, N., Faller, J.-P., Sekri, D., Hoen, B., Talon, D. R., & Bertrand, X. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9606-6 · Cited by 44
Schneeweiß, S., Maclure, M., Soumerai, S. B., Walker, A. M., & Glynn, R. J. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00437-7 · Cited by 44
Gurwitz, J. H., McLaughlin, T., & Fish, L. S. (1995) · PubMed · Cited by 43
Fischer, M. A., Choudhry, N. K., & Winkelmayer, W. C. (2007) · Health Affairs · doi:10.1377/hlthaff.26.3.800 · Cited by 43
Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States
Pinheiro, S. P., Kang, E. M., Kim, C. Y., Governale, L. A., Zhou, E. H., & Hammad, T. A. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3481 · Cited by 42
Impact of a drug bulletin on prescribing oral analgesics in a teaching hospital
Berbatis, C. G., Maher, M. J., Plumridge, R. J., Stoelwinder, J. U., & Zubrick, S. R. (1982) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/39.1.98 · Cited by 42
Effect of switching to a high-deductible health plan on use of chronic medications.
Reiss, S., Ross-Degnan, D., Zhang, F., Soumerai, S., Zaslavsky, A., & Wharam, J. (2011) · Health Services Research · doi:10.1111/j.1475-6773.2011.01252.x · Cited by 41
Randomized clinical trials and recent patterns in the use of statins
Wang, T. J., Stafford, R. S., Ausiello, J. C., & Chaisson, C. E. (2001) · American Heart Journal · doi:10.1067/mhj.2001.115587 · Cited by 41
Improving Evidence-Based Care in Cystic Fibrosis Through Quality Improvement
McPhail, G. L., Weiland, J., Acton, J. D., Ednick, M., Chima, A., VanDyke, R. D., Fenchel, M. C., Amin, R. S., & Seid, M. (2010) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2010.178 · Cited by 41
Did Copayment Changes Reduce Health Service Utilization among CHIP Enrollees? Evidence from A labama
Sen, B., Blackburn, J. L., Morrisey, M. A., Kilgore, M. L., Becker, D. J., Caldwell, C., & Menachemi, N. (2012) · Health Services Research · doi:10.1111/j.1475-6773.2012.01384.x · Cited by 41
Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans
Roughead, E. E., Ellett, L. M. K., Ramsay, E. N., Pratt, N. L., Barratt, J. D., LeBlanc, V. T., Ryan, P., Peck, R., Killer, G. T., & Gilbert, A. L. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-514 · Cited by 41
Bergen, H. A., Hawton, K. E., Murphy, E., Cooper, J., Kapur, N., Stalker, C., & Waters, K. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03481.x · Cited by 41
Gilson, A. M., Fishman, S. M., Wilsey, B. L., et al. (2011) · Journal of Pain · doi:10.1016/j.jpain.2011.09.006 · Cited by 40
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Effects of FDA Advisories on the Pharmacologic Treatment of ADHD, 2004–2008
Kornfield, R., Watson, S., Higashi, A. S., Conti, R. M., Dusetzina, S. B., Garfield, C. F., Dorsey, E. R., Huskamp, H. A., & Alexander, G. C. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200147 · Cited by 40
Schneeweiß, S., Patrick, A. R., Maclure, M., Dormuth, C. R., & Glynn, R. J. (2007) · PubMed · Cited by 39
Prior Authorization for Antidepressants in Medicaid
Adams, A. S., Zhang, F., LeCates, R. F., Graves, A. J., Ross‐Degnan, D., Gilden, D., McLaughlin, T. J., Lu, C. Y., Trinacty, C. M., & Soumerai, S. B. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.39 · Cited by 39
Medicaid Prior Authorization and Controlled-Release Oxycodone
Morden, N. E., Zerzan, J. T., Rue, T. C., Heagerty, P. J., Roughead, E. E., Soumerai, S. B., Ross‐Degnan, D., & Sullivan, S. D. (2008) · Medical Care · doi:10.1097/mlr.0b013e31816493fb · Cited by 39
Schneeweiß, S., Maclure, M., Walker, A. M., Grootendorst, P. V., & Soumerai, S. B. (2001) · Health Policy · doi:10.1016/s0168-8510(00)00120-2 · Cited by 39
MacBride‐Stewart, S., Elton, R. A., & Walley, T. (2008) · Family Practice · doi:10.1093/fampra/cmm074 · Cited by 39
HARTUNG, D., Touchette, D. R., Ketchum, K. L., Haxby, D. G., & GOLDBERG, B. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.09.013 · Cited by 39
Effect of clinical trial publicity on HRT prescribing in Ireland
Usher, C., Teeling, M., Bennett, K., & Feely, J. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0083-x · Cited by 38
Measuring change in prescription drug utilization in Australia
Mandryk, J. A., Mackson, J. M., Horn, F. E., Wutzke, S. E., Badcock, C., Hyndman, R. J., & Weekes, L. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1247 · Cited by 38
Breen, C. L., Degenhardt, L. J., Roxburgh, A., Bruno, R., & Jenkinson, R. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06293.x · Cited by 38
Impact of generic substitution decision support on electronic prescribing behavior
Stenner, S. P., Chen, Q., & Johnson, K. B. (2010) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.2009.002568 · Cited by 37
Tängdén, T., Eriksson, B., Melhus, Å., Svennblad, B., & Cars, O. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr053 · Cited by 37
The effects of new pricing and copayment schemes for pharmaceuticals in South Korea
Lee, I., Bloor, K. E., Hewitt, C. E., & Maynard, A. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.09.003 · Cited by 36
Thamer, Ray, N. F., Henderson, S. C., Rinehart, C. S., Sherman, C. R., & Ferguson, J. H. (1998) · Medical Care · doi:10.1097/00005650-199805000-00005 · Cited by 36
The Impact of the Women's Health Initiative on Hormone Replacement Therapy in a Medicaid Program
Hillman, J. J., Zuckerman, I. H., & Lee, E. (2004) · Journal of Women s Health · doi:10.1089/jwh.2004.13.986 · Cited by 36
Nursing Home Residents and Enrollment in Medicare Part D
Briesacher, B. A., Soumerai, S. B., Field, T. S., Fouayzi, H., & Gurwitz, J. H. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02454.x · Cited by 35
Impact of Safety Warnings on Drug Utilization: Marketplace Life Span of Cisapride and Troglitazone
Wilkinson, J. J., Force, R. W., & Cady, P. S. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.11.978.36136 · Cited by 35
Xie, F., Petitti, D. B., & Chen, W. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.004 · Cited by 35
Hulgan, T., Rosenbloom, S. T., Hargrove, F. R., Talbert, D. A., Arbogast, P. G., Bansal, P., Miller, R. A., & Kernodle, D. S. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01375.x · Cited by 35
Lu, C. Y., Law, M. R., Soumerai, S. B., Graves, A. J., LeCates, R. F., Zhang, F., Ross‐Degnan, D., & Adams, A. S. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.012 · Cited by 35
Impact of Safety-Related Regulatory Action on Drug Use in Ambulatory Care in the Netherlands
Piening, S., Reber, K. C., Wieringa, J. E., Straus, S. M. J. M., de Graeff, P. A., Haaijer‐Ruskamp, F. M., & Mol, P. G. M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.308 · Cited by 35
Prescribing of smoking cessation medication in England since the introduction of varenicline
Langley, T. E., Huang, Y. S., McNeill, A. D., Coleman, T. J., Szatkowski, L., & Lewis, S. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03426.x · Cited by 35
Racial Disparities in Access After Regulatory Surveillance of Benzodiazepines
Pearson, S.-A., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Salzman, C., Cosler, L. E., Fanning, T., Gallagher, P., & Ross-Degnan, D. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.5.572 · Cited by 34
Meyer, E., Schwab, F., Pollitt, A., Bettolo, W., Schroeren-Boersch, B., & Trautmann, M. (2009) · Infection · doi:10.1007/s15010-009-9115-2 · Cited by 33
Ong, M., Catalano, R. A., & Hartig, T. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80082-6 · Cited by 33
Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden
Godman, B., Persson, M., Miranda, J., Skiöld, P., Wettermark, B., Barbui, C., & Gustafsson, L. L. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0037-x · Cited by 33
Lurk, J. T., DeJong, D. J., Woods, T. M., Knell, M. E., & Carroll, C. A. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.3.267 · Cited by 32
Changes in Fluoroquinolone Use for Gonorrhea Following Publication of Revised Treatment Guidelines
Dowell, D., Tian, L. H., Stover, J. A., Donnelly, J. A., Martins, S. L., Erbelding, E. J., Pino, R., Weinstock, H., & Newman, L. M. (2011) · American Journal of Public Health · doi:10.2105/ajph.2011.300283 · Cited by 32
Hynd, A., Roughead, E. E., Preen, D. B., Glover, J. D., Bulsara, M. K., & Semmens, J. B. (2009) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2009.00383.x · Cited by 32
Shrank, W. H., Patrick, A. R., Pedan, A., Polinski, J. M., Varasteh, L. T., Levin, R., Liu, N., & Schneeweiß, S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02025.x · Cited by 32
Mishra, G. D., Kok, H. S., Ecob, R., Cooper, R., Hardy, R., & Kuh, D. J. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.071332 · Cited by 31
Chen, H., Nwangwu, A., Aparasu, R. R., Essien, E. J., Sun, S. X., & Lee, K. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.10.1191 · Cited by 31
Roughead, E. E., Zhang, F., Ross‐Degnan, D., & Soumerai, S. B. (2006) · Medical Care · doi:10.1097/01.mlr.0000204056.31664.36 · Cited by 31
Shifting Physician Prescribing to a Preferred Histamine-2-Receptor Antagonist
Brufsky, J. W., Ross‐Degnan, D., Calabrese, D., Gao, X., & Soumerai, S. B. (1998) · Medical Care · doi:10.1097/00005650-199803000-00009 · Cited by 31
Szatkowski, L., Coleman, T. J., McNeill, A. D., & Lewis, S. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03494.x · Cited by 30
Donnelly, N., McManus, P. R., Dudley, J., et al. (2000) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2000.tb00524.x · Cited by 30
Pape, U. J., Millett, C. J., Lee, J. T., Car, J., & Majeed, A. (2013) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2012.110319 · Cited by 30
Stewart, K., Natzke, B., Williams, T. V., Granger, E., Casscells, S. W., & Croghan, T. W. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1819 · Cited by 29
Reducing the Use of H 2 ‐Receptor Antagonists in the Long‐Term‐Care Setting
Gurwitz, J. H., Noonan, J. P., & Soumerai, S. B. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb02135.x · Cited by 29
Garabedian, L. F., Ross‐Degnan, D., Ratanawijitrasin, S., Stephens, P. N., & Wagner, A. K. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001686 · Cited by 29
Hadi, U., Keuter, M., van Asten, H., van den Broek, P., & on behalf of the study group ‘Antimicrobial resistance in Indonesia: Prevalence and Prevention’ (AMRIN) (2008) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02080.x · Cited by 28
Optimizing use of ciprofloxacin: a prospective intervention study
van Hees, B. C., de Ruiter, E., Wiltink, E. H. H., de Jongh, B. M., & Tersmette, M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm388 · Cited by 28
Hypertension guidelines in elderly patients: is anybody listening?
Tu, K., Mamdani, M., & Tu, J. V. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01144-0 · Cited by 28
Self-citationPettersson, B., Hoffmann, M., Andersson, D., Wändell, P. E., & Levin, L. (2012) · Health Policy · doi:10.1016/j.healthpol.2012.10.008 · Cited by 28
An Outreach Program Improved Osteoporosis Management After a Fracture
Feldstein, A. C., Vollmer, W. M., Smith, D. H., Petrik, A. F., Schneider, J., Glauber, H. S., & Herson, M. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01310.x · Cited by 27
Umscheid, C. A., Hanish, A., Chittams, J. L., Weiner, M. G., & Hecht, T. E. H. (2012) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-12-92 · Cited by 27
Sreeharan, V., Madden, H., Lee, J. T., Millett, C. J., & Majeed, A. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x671641 · Cited by 27
Changes in the Use of Broad-Spectrum Antibiotics after Cefepime Shortage: a Time Series Analysis
Plüss-Suard, C., Pannatier, A., Ruffieux, C., Kronenberg, A., Mühlemann, K., & Zanetti, G. M. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05560-11 · Cited by 26
Marshall, D. A., Gough, J., Grootendorst, P. V., Buitendyk, M., Jaszewski, B., Simonyi, S., Jivraj, F., & MacLeod, S. M. (2005) · Journal of Health Services Research & Policy · doi:10.1258/135581906775094253 · Cited by 26
Boruett, P., Kagai, D., Njogo, S., Nguhiu, P. K., Awuor, C., Gitau, L., Chalker, J. C., Ross‐Degnan, D., Wahlström, R., & Tomson, G. B. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-242 · Cited by 26
Venekamp, R. P., Rovers, M. M., Verheij, T. J., Bonten, M. J. M., & Sachs, A. P. E. (2012) · Family Practice · doi:10.1093/fampra/cms022 · Cited by 26
Cortina, S., Somers, M., Rohan, J. M., & Drotar, D. (2013) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jss175 · Cited by 26
The Impact of Cost Sharing on Antidepressant Use Among Older Adults in British Columbia
Wang, P. S., Patrick, A. R., Dormuth, C. R., Avorn, J., Maclure, M., Canning, C. F., & Schneeweiß, S. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.4.377 · Cited by 26
Effect of copayments on drug use in the presence of annual payment limits.
Kephart, G. C., Skedgel, C. D., SKETRIS, I. S., et al. (2007) · PubMed · Cited by 26
Fisher, J. E., Zhang, Y., SKETRIS, I. S., Johnston, G. M., & Burge, F. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2259 · Cited by 25
Application of Regression‐Discontinuity Analysis in Pharmaceutical Health Services Research
Zuckerman, I. H., Lee, E., Wutoh, A. K., Xue, Z., & Stuart, B. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.00487.x · Cited by 25
Impact of a Cost‐Sharing Drug Insurance Plan on Drug Utilization Among Older People
Blais, L., Boucher, J., Couture, J., Rahme, E., & LeLorier, J. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49084.x · Cited by 25
A controlled trial of value-based insurance design – The MHealthy: Focus on Diabetes (FOD) trial
Spaulding, A. B., Fendrick, A. M., Herman, W. H., Stevenson, J. G., Smith, D. G., Chernew, M. E., Parsons, D., Bruhnsen, K. D., & Rosen, A. B. (2009) · Implementation Science · doi:10.1186/1748-5908-4-19 · Cited by 25
Verbiest, M. E. A., Chavannes, N. H., Crone, M. R., Nielen, M. M. J., Segaar, D., Korevaar, J. C., & Assendelft, W. J. (2013) · Addiction · doi:10.1111/add.12289 · Cited by 25
Effectiveness of Safety Warnings in Atypical Antipsychotic Drugs
Sanfélix‐Gimeno, G., Cervera-Casino, P., Peiró, S., López‐Valcárcel, B. G., Blázquez, M. A., & Barberá, T. (2009) · Drug Safety · doi:10.2165/11316520-000000000-00000 · Cited by 24
Bennie, M., Bishop, I., Godman, B., Campbell, S., Miranda, J., Finlayson, A. E. T., & Gustafsson, L. L. (2013) · PubMed · Cited by 23
Mamdani, M., Warren, L., Kopp, A., Paterson, J. M., Laupacis, A., Bassett, K. L., & Anderson, G. M. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050192 · Cited by 23
Self-citationFretheim, A., Håvelsrud, K., MacLennan, G., Kristoffersen, D. T., & Oxman, A. D. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040232 · Cited by 23
Colombet, I., Sabatier, B., Gillaizeau, F., Prognon, P., Bégué, D., & Durieux, P. (2009) · BMJ Quality & Safety · doi:10.1136/qshc.2007.023887 · Cited by 23
Primary care prescribing patterns in Ireland after the publication of large hypertension trials
Kabir, Z., Feely, J., & Bennett, K. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02896.x · Cited by 22
Hesse, U., Godman, B., Petzold, M., Martin, A. A., & Malmström, R. E. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0059-4 · Cited by 22
Roughead, E. E., Ramsay, E. N., Pratt, N. L., & Gilbert, A. L. (2008) · Drug Safety · doi:10.2165/00002018-200831110-00004 · Cited by 22
Clinical Evidence, Practice Guidelines, and β-Blocker Utilization Before Major Noncardiac Surgery
Wijeysundera, D. N., Mamdani, M., Laupacis, A., Fleisher, L. A., Beattie, W. S., Johnson, S. R., Kolstad, J., & Neuman, M. D. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.965632 · Cited by 22
Self-citationPichetti, S., Sorasith, C., & Sermet, C. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.07.001 · Cited by 21
Wheeler, B. W., Metcalfe, C., Gunnell, D., Stephens, P. J., & Martin, R. M. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03500.x · Cited by 21
Effect of Drug Sample Removal on Prescribing in a Family Practice Clinic
Hartung, D. M., Evans, D., Haxby, D. G., Kraemer, D. F., Andeen, G., & Fagnan, L. J. (2010) · The Annals of Family Medicine · doi:10.1370/afm.1135 · Cited by 21
Horn, F. E., Mandryk, J. A., Mackson, J. M., Wutzke, S. E., Weekes, L., & Hyndman, R. J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1243 · Cited by 21
Andersen, S. E., Knudsen, J. D., & for the Bispebjerg Intervention Group (2013) · BMJ Quality & Safety · doi:10.1136/bmjqs-2012-001791 · Cited by 21
Lam, N. N., Jain, A. K., Hackam, D. G., Cuerden, M. S., Suri, R. S., Huo, C. Y., Li, P., Clark, W. F., & Garg, A. X. (2009) · Kidney International · doi:10.1038/ki.2009.323 · Cited by 20
Bucsics, A., Godman, B., Burkhardt, T. H., Schmitzer, M., & Malmström, R. E. (2012) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.12.71 · Cited by 20
Cited by
Schaffer, A. L., Dobbins, T. A., & Pearson, S.-A. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01235-8 · Cited by 794
Angoulvant, F., Ouldali, N., Yang, D. D., Filser, M., Gajdos, V., Rybak, A., Guedj, R., Soussan-Banini, V., Basmaci, R., Lefevre-Utile, A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa710 · Cited by 306
Critical care transition programs and the risk of readmission or death after discharge from ICU.
Stelfox, H. T., Bastos, J., Niven, D. J., Bagshaw, S. M., Turin, T. C., & Gao, S. (2016) · Intensive Care Medicine · doi:10.1007/s00134-015-4173-7 · Cited by 60
Cross-sectional studies: strengths, limitations, and methodological considerations
Baumeister, S., Kocher, T., Papapanou, P. N., Holtfreter, B., & Demmer, R. T. (2026) · Journal of Periodontal Research · doi:10.1111/jre.70063 · Cited by 38
Rahemtulla, K. A., Cheema, M. K., Nickonchuk, T., Guirguis, M., Al Hamarneh, Y. N., & Damji, K. F. (2022) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2021.06.005 · Cited by 11
Metadata
- Authors
- Jandoc, R., Burden, A. M., Mamdani, M., Lévesque, L. E., & Cadarette, S. M.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 68
- Issue
- 8
- Pages
- 950-956
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2119863846
- Cited by
- 474
- References
- 231
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.